MedPage Today on MSN
FDA Approves Maintenance Combo for Small Cell Lung Cancer
The FDA approved lurbinectedin (Zepzelca) plus either atezolizumab (Tecentriq) or atezolizumab and hyaluronidase (Tecentriq ...
The FDA approved the combination of lurbinectedin and atezolizumab as first-line maintenance treatment for certain adults ...
Previously, the primary endpoint results of the NRG-LU005 study assessing the addition of the immunotherapy drug atezolizumab ...
Blueair has just launched its new Sleep collection featuring two new air treatment products, designed to help you sleep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback